NCT00006012 arm group 7dbc709d5518104ad6235031c6c06616 [clinicaltrials_resource:NCT00006012/arm-group/7dbc709d5518104ad6235031c6c06616]
cisplatin [clinicaltrials_resource:1f3217f016a4cf07fc0085c5ae56abd9]filgrastim [clinicaltrials_resource:2f897f1297dbf6c3a65648d32d364938]amifostine trihydrate [clinicaltrials_resource:3e6898700ce4fb5ce04403d77e144396]paclitaxel [clinicaltrials_resource:93b0f962cc8fc9bc2b25ac4f8713d799]radiation therapy [clinicaltrials_resource:94497134f72deab9debed98bff435cc8]etoposide [clinicaltrials_resource:bb8cbdaef582997437006ea0f5ee20f4]topotecan hydrochloride [clinicaltrials_resource:f49b244ec7291a327e6b4a6846a14031]clinicaltrials:NCT00006012
arm group [clinicaltrials_vocabulary:arm-group]
NCT00006012 arm group 7dbc709d5518104ad6235031c6c06616 [clinicaltrials_resource:NCT00006012/arm-group/7dbc709d5518104ad6235031c6c06616]
Bio2RDF identifier
NCT00006012/arm-group/7dbc709d5518104ad6235031c6c06616
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... bc709d5518104ad6235031c6c06616
description [clinicaltrials_vocabulary:description]
Patients receive topotecan IV ...... en every 6 months for 3 years.
identifier
clinicaltrials_resource:NCT00006012/arm-group/7dbc709d5518104ad6235031c6c06616
title
NCT00006012 arm group 7dbc709d5518104ad6235031c6c06616
@en
type
label
NCT00006012 arm group 7dbc709d ...... c709d5518104ad6235031c6c06616]
@en